Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
The fibrin constituent containing a strontium compound
Document Type and Number:
Japanese Patent JP6012551
Kind Code:
B2
Abstract:
The present invention relates to a composition comprising fibrinogen, thrombin and a strontium-containing compound for use in bone healing or bone growth, wherein strontium is present in a 25% strontium substituted particle, optionally wherein said composition is resorbed and replaced with tissue during the healing process.

Inventors:
John Jay Barry
Andreas Gothul
Gerald Zimmer
Application Number:
JP2013130650A
Publication Date:
October 25, 2016
Filing Date:
June 21, 2013
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BAXTER INTERNATIONAL INCORP0RATED
Baxter Healthcare SA
International Classes:
A61K33/14; A61K9/06; A61K9/08; A61K31/663; A61K33/06; A61K38/00; A61K38/22; A61K38/48; A61K47/10; A61K47/18; A61K47/26; A61K47/36; A61K49/04; A61P19/08
Domestic Patent References:
JP2008526810A
JP2001527020A
JP2005531341A
Foreign References:
WO2006072622A1
Other References:
MARIE, P.J. et al,An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and mainta,J. Bone Miner. Res.,1993年,Vol.8, No.5,p.607-615
J. Biomed. Mater. Res. A. 2004, Vol.70, No.3, p.428-435
J. Biomed. Mate.r Res. A. 2006, Vol.79, No.4, p.804-814
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita